Shattuck Labs, Inc. (STTK) NASDAQ
5.18
-0.4713(-8.34%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Shattuck Labs, Inc.
Address
500 West 5th Street
Austin, TX 78703
United States of America (the)
Phone
512 900 4690
Website
Sector
Healthcare
Industry
Biotechnology
Employees
44
First IPO Date
October 09, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Taylor H. Schreiber | Co-Founder, Chief Executive Officer & Director | 876,232 | 1980 |
| Casi DeYoung | Chief Business Officer | 523,482 | 1971 |
| Abhinav A. Shukla | Chief Technical Officer | 567,398 | 1974 |
| Andrew R. Neill | Chief Financial Officer | 678,207 | 1986 |
| Arundathy Nirmalini Pandite | Chief Medical Officer | 734,899 | 1959 |
| Thomas Lampkin | Senior Vice President of Regulatory Affairs | 0 | N/A |
| Kelli Collin | Senior Vice President of Quality | 0 | N/A |
| Stephen Stout | General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | 0 | 1976 |
| Brad Huckabee | Vice President of Accounting & SEC reporting | 0 | N/A |
| Suresh de Silva | Chief Scientific Officer | 0 | N/A |
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
